PRLR and colonic neoplasm: To answer this question, we treated MALME-3M (human melanoma) and T84 (human colon cancer) cells with either 2.5 nM hGH or hPRL in the absence or presence of S1H and quantified the level of pSTAT5 by Western blotting (Fig. 5).